Hanna NH - Search Results

1

Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).

Taza F, Abonour R, Zaid MA, Althouse SK, Anouti B, Akel R, Hanna NH, Adra N, Einhorn LH. Taza F, et al. Among authors: hanna nh. Clin Genitourin Cancer. 2023 Apr;21(2):213-220. doi: 10.1016/j.clgc.2023.01.004. Epub 2023 Jan 18. Clin Genitourin Cancer. 2023. PMID: 36737276

2

High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.

Hanna N, Gharpure VS, Abonour R, Cornetta K, Loehrer PJ Sr. Hanna N, et al. Bone Marrow Transplant. 2001 Sep;28(5):435-8. doi: 10.1038/sj.bmt.1703181. Bone Marrow Transplant. 2001. PMID: 11593315 Clinical Trial.

3

Diagnostic and therapeutic quandaries in a patient with a germ cell tumor.

Hanna N, Kesler K, Einhorn L. Hanna N, et al. J Clin Oncol. 2001 Oct 15;19(20):4088. doi: 10.1200/JCO.2001.19.20.4088. J Clin Oncol. 2001. PMID: 11600612 No abstract available.

4

Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.

Hanna NH, Sandier AB, Loehrer PJ Sr, Ansari R, Jung SH, Lane K, Einhorn LH. Hanna NH, et al. Ann Oncol. 2002 Jan;13(1):95-102. doi: 10.1093/annonc/mdf014. Ann Oncol. 2002. PMID: 11863118 Free article. Clinical Trial.

5

Primary choriocarcinoma of the bladder with the detection of isochromosome 12p.

Hanna NH, Ulbright TM, Einhorn LH. Hanna NH, et al. J Urol. 2002 Apr;167(4):1781. J Urol. 2002. PMID: 11912411 No abstract available.

6

The value of platinum compounds in non-small-cell lung cancer.

Hanna NH, Einhorn LH. Hanna NH, et al. Clin Lung Cancer. 2002 May;3(4):249-53. doi: 10.3816/clc.2002.n.008. Clin Lung Cancer. 2002. PMID: 14662032

7

Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment.

Shafqat A, Einhorn LH, Hanna N, Sledge GW, Hanna A, Juliar BE, Monahan P, Bhatia S. Shafqat A, et al. Ann Oncol. 2005 Sep;16(9):1545-50. doi: 10.1093/annonc/mdi267. Epub 2005 May 26. Ann Oncol. 2005. PMID: 15919683 Free article.

8

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial.

Moore AM, Einhorn LH, Estes D, Govindan R, Axelson J, Vinson J, Breen TE, Yu M, Hanna NH. Moore AM, et al. Among authors: hanna nh. Lung Cancer. 2006 Apr;52(1):93-7. doi: 10.1016/j.lungcan.2005.12.002. Epub 2006 Feb 20. Lung Cancer. 2006. PMID: 16488055 Clinical Trial.

9

Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.

Hammoud ZT, Kesler KA, Ferguson MK, Battafarrano RJ, Bhogaraju A, Hanna N, Govindan R, Mauer AA, Yu M, Einhorn LH. Hammoud ZT, et al. Dis Esophagus. 2006;19(2):69-72. doi: 10.1111/j.1442-2050.2006.00542.x. Dis Esophagus. 2006. PMID: 16643172

10

Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but gray.

Hanna NH, Einhorn LH. Hanna NH, et al. J Clin Oncol. 2006 Dec 10;24(35):5611-2; author reply 5612-3. doi: 10.1200/JCO.2006.09.1504. J Clin Oncol. 2006. PMID: 17158549 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters